1-Acylglycerol-3-Phosphate O-Acyltransferase 2 (Lysophosphatidic Acid Acyltransferase, Beta) (AGPAT2) Peptide
Our Local Distributor
北京 101111
Quick Overview for 1-Acylglycerol-3-Phosphate O-Acyltransferase 2 (Lysophosphatidic Acid Acyltransferase, Beta) (AGPAT2) Peptide (ABIN940260)
抗原
宿主
资源
应用范围
-
-
蛋白类型
- Synthetic
-
序列
- LEAIPTSGLT AADVPALVDT CHRAMRTTFL HISKTPQENG ATAGSGVQPA
-
产品特性
-
A synthetic peptide for use as a blocking control in assays to test for specificity of AGPAT2 antibody,
Alternative Names: AGPAT2 control peptide, AGPAT2 antibody Blocking Peptide, Anti-AGPAT2 Blocking Peptide, 1-Acylglycerol-3-Phosphate O-Acyltransferase 2 Blocking Peptide, ,1-AGPAT2 Blocking Peptide, BSCL Blocking Peptide, BSCL1 Blocking Peptide, LPAAB Blocking Peptide, LPAAT-beta Blocking Peptide
-
-
-
-
应用备注
- Optimal conditions should be determined by the investigator
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
缓冲液
- PBS
-
注意事项
- Avoid repeated freeze/thaw cycles.
-
储存条件
- -20 °C
-
储存方法
- Store at -20 °C long term.
-
-
- AGPAT2 (1-Acylglycerol-3-Phosphate O-Acyltransferase 2 (Lysophosphatidic Acid Acyltransferase, Beta) (AGPAT2))
-
背景
- AGPAT2 is a member of the 1-acylglycerol-3-phosphate O-acyltransferase family. The protein is located within the endoplasmic reticulum membrane and converts lysophosphatidic acid to phosphatidic acid, the second step in de novo phospholipid biosynthesis. Mutations in its gene have been associated with congenital generalized lipodystrophy (CGL), or Berardinelli-Seip syndrome, a disease characterized by a near absence of adipose tissue and severe insulin resistance.
-
分子量
- 27 kDa
抗原
-